Neuregulin expression in solid tumors: prognostic value and predictive role to anti-HER3 therapies.
about
Heregulin-1ß and HER3 in hepatocellular carcinoma: status and regulation by insulin.Clinical significance of overexpression of NRG1 and its receptors, HER3 and HER4, in gastric cancer patients.EV20-Sap, a novel anti-HER-3 antibody-drug conjugate, displays promising antitumor activity in melanoma.The role of NRG1 in the predisposition to papillary thyroid carcinoma.Phase 1/2 study of rilotumumab (AMG 102), a hepatocyte growth factor inhibitor, and erlotinib in patients with advanced non-small cell lung cancer.
P2860
Neuregulin expression in solid tumors: prognostic value and predictive role to anti-HER3 therapies.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 08 April 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Neuregulin expression in solid ...... e role to anti-HER3 therapies.
@en
Neuregulin expression in solid ...... e role to anti-HER3 therapies.
@nl
type
label
Neuregulin expression in solid ...... e role to anti-HER3 therapies.
@en
Neuregulin expression in solid ...... e role to anti-HER3 therapies.
@nl
prefLabel
Neuregulin expression in solid ...... e role to anti-HER3 therapies.
@en
Neuregulin expression in solid ...... e role to anti-HER3 therapies.
@nl
P2860
P50
P356
P1433
P1476
Neuregulin expression in solid ...... e role to anti-HER3 therapies.
@en
P2093
Atanasio Pandiella
Laura Díez-González
P2860
P304
45042-45051
P356
10.18632/ONCOTARGET.8648
P407
P577
2016-04-08T00:00:00Z